153 related articles for article (PubMed ID: 30190751)
1. Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients.
Mohamad WMW; Jia SK; Ghazali WSW; Taib H
Pak J Med Sci; 2018; 34(4):907-912. PubMed ID: 30190751
[TBL] [Abstract][Full Text] [Related]
2. Periodontal health status, Porphyromonas gingivalis and anti-cyclic citrullinated peptide antibodies among rheumatoid arthritis patients.
Wan Jiun T; Taib H; Majdiah Wan Mohamad W; Mohamad S; Syamimee Wan Ghazali W
Int Immunopharmacol; 2023 Nov; 124(Pt B):110940. PubMed ID: 37722261
[TBL] [Abstract][Full Text] [Related]
3. Association between periodontitis and anti-citrullinated protein antibodies in rheumatoid arthritis patients: a cross-sectional study.
González-Febles J; Rodríguez-Lozano B; Sánchez-Piedra C; Garnier-Rodríguez J; Bustabad S; Hernández-González M; González-Dávila E; Sanz M; Díaz-González F
Arthritis Res Ther; 2020 Feb; 22(1):27. PubMed ID: 32054521
[TBL] [Abstract][Full Text] [Related]
4. Periodontal pathogens and the association between periodontitis and rheumatoid arthritis in Korean adults.
Kim JH; Choi IA; Lee JY; Kim KH; Kim S; Koo KT; Kim TI; Seol YJ; Ku Y; Rhyu IC; Song YW; Lee YM
J Periodontal Implant Sci; 2018 Dec; 48(6):347-359. PubMed ID: 30619636
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti-Cyclic Citrullinated Protein Antibody-Positive At-Risk Adults Without Arthritis.
Mankia K; Cheng Z; Do T; Hunt L; Meade J; Kang J; Clerehugh V; Speirs A; Tugnait A; Hensor EMA; Nam JL; Devine DA; Emery P
JAMA Netw Open; 2019 Jun; 2(6):e195394. PubMed ID: 31173126
[TBL] [Abstract][Full Text] [Related]
6. The role of anti-cyclic citrullinated peptide antibody in periodontal disease.
Ballini A; Tetè S; Scattarella A; Cantore S; Mastrangelo F; Papa F; Nardi GM; Perillo L; Crincoli V; Gherlone E; Grassi FR
Int J Immunopathol Pharmacol; 2010; 23(2):677-81. PubMed ID: 20646367
[TBL] [Abstract][Full Text] [Related]
7. Impact of Cyclic Citrullinated Peptide Antibody Level on Progression to Rheumatoid Arthritis in Clinically Tested Cyclic Citrullinated Peptide Antibody-Positive Patients Without Rheumatoid Arthritis.
Ford JA; Liu X; Marshall AA; Zaccardelli A; Prado MG; Wiyarand C; Lu B; Karlson EW; Schur PH; Deane KD; Sparks JA
Arthritis Care Res (Hoboken); 2019 Dec; 71(12):1583-1592. PubMed ID: 30570827
[TBL] [Abstract][Full Text] [Related]
8. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis.
Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H
J Periodontal Res; 2016 Feb; 51(1):103-11. PubMed ID: 26094771
[TBL] [Abstract][Full Text] [Related]
9. Periodontitis is associated with rheumatoid arthritis: a study with longstanding rheumatoid arthritis patients in Korea.
Choi IA; Kim JH; Kim YM; Lee JY; Kim KH; Lee EY; Lee EB; Lee YM; Song YW
Korean J Intern Med; 2016 Sep; 31(5):977-86. PubMed ID: 27017391
[TBL] [Abstract][Full Text] [Related]
10. Anti-cyclic citrullinated peptide antibody is a good indicator for the diagnosis of rheumatoid arthritis.
Abdul Wahab A; Mohammad M; Rahman MM; Mohamed Said MS
Pak J Med Sci; 2013 May; 29(3):773-7. PubMed ID: 24353626
[TBL] [Abstract][Full Text] [Related]
11. Anti-cyclic citrullinated Peptide antibody: an early diagnostic and prognostic biomarker of rheumatoid arthritis.
Manivelavan D; C K V
J Clin Diagn Res; 2012 Oct; 6(8):1393-6. PubMed ID: 23205355
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of treatment patterns and healthcare utilization of newly-diagnosed rheumatoid arthritis patients by anti-cyclic citrullinated peptide antibody status.
Lamerato L; Price K; Szymialis R; Eaddy M; Ogbonnaya A; Shih HC; Ahmad H
J Med Econ; 2018 Mar; 21(3):231-240. PubMed ID: 29027497
[TBL] [Abstract][Full Text] [Related]
13. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.
van der Helm-van Mil AH; Verpoort KN; Breedveld FC; Huizinga TW; Toes RE; de Vries RR
Arthritis Rheum; 2006 Apr; 54(4):1117-21. PubMed ID: 16572446
[TBL] [Abstract][Full Text] [Related]
14. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the analytical and clinical performances of four anti-cyclic citrullinated peptide antibody assays for diagnosing rheumatoid arthritis.
Cho J; Pyo JY; Fadriquela A; Uh Y; Lee JH
Clin Rheumatol; 2021 Feb; 40(2):565-573. PubMed ID: 32964298
[TBL] [Abstract][Full Text] [Related]
16. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
Svärd A; Kastbom A; Söderlin MK; Reckner-Olsson Å; Skogh T
J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
[TBL] [Abstract][Full Text] [Related]
17. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
[TBL] [Abstract][Full Text] [Related]
18. Association of levels of antibodies against citrullinated cyclic peptides and citrullinated α-enolase in chronic and aggressive periodontitis as a risk factor of Rheumatoid arthritis: a case control study.
Reichert S; Schlumberger W; Dähnrich C; Hornig N; Altermann W; Schaller HG; Schulz S
J Transl Med; 2015 Aug; 13():283. PubMed ID: 26319714
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J
Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519
[TBL] [Abstract][Full Text] [Related]
20. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
